CL

Chih-Jian Lih

UA University Of Arizona: 2 patents #250 of 1,318Top 20%
BB British Columbia Cancer Agency Branch: 2 patents #55 of 171Top 35%
HB Hospital Clínic De Barcelona: 2 patents #27 of 102Top 30%
UB Universitat De Barcelona: 2 patents #29 of 194Top 15%
OU Oregon Health & Science University: 1 patents #352 of 725Top 50%
OH Oslo University Hospital Hf: 1 patents #47 of 65Top 75%
RS Roche Molecular Systems: 1 patents #392 of 746Top 55%
UN University Of Nebraska: 1 patents #349 of 808Top 45%
Stanford University: 1 patents #2,251 of 5,197Top 45%
CC Cleveland Clinic: 1 patents #483 of 972Top 50%
JW Julius-Maximilians-Universitat Wurzburg: 1 patents #69 of 200Top 35%
📍 Gaithersburg, MD: #466 of 1,746 inventorsTop 30%
🗺 Maryland: #8,004 of 35,612 inventorsTop 25%
Overall (All Time): #1,123,112 of 4,157,543Top 30%
4
Patents All Time

Issued Patents All Time

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDate
11574704 Method for subtyping lymphoma types by means of expression profiling Louis M. Staudt, George W. Wright, David William Scott, Joseph M. Connors, Randy D. Gascoyne +15 more 2023-02-07
10607717 Method for subtyping lymphoma types by means of expression profiling Louis M. Staudt, George W. Wright, David William Scott, Joseph M. Connors, Randy D. Gascoyne +15 more 2020-03-31
8691780 Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby Stanley N. Cohen 2014-04-08
8592156 Predicting response to anti-CD20 therapy in DLBCL patients Wei-Min Liu, Yan Li, Yu Chuan Tai 2013-11-26